| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adipose tissue autophagy and homeostasis in alcohol-induced liver injury
|
Li, Yuan
|
|
2017
|
|
1 |
p. 54-62
9 p.
|
artikel
|
| 2 |
A dual role of inflammation in acetaminophen-induced liver injury
|
Xu, Long
|
|
|
|
1 |
p. 9-15
|
artikel
|
| 3 |
A fluorescence imaging based-assay to monitor mitophagy in cultured hepatocytes and mouse liver
|
Ma, Xiaowen
|
|
|
|
1 |
p. 16-20
|
artikel
|
| 4 |
Alcoholic liver disease and mast cells: What's your gut got to do with it?
|
Tolefree, Julie Ann
|
|
2019
|
|
1 |
p. 46-54
|
artikel
|
| 5 |
Altered gut-liver axis in liver diseases
|
Zhou, Huiping
|
|
2019
|
|
1 |
p. 1-2
|
artikel
|
| 6 |
A novel nomogram based on routine clinical indicators for screening for Wilson's disease
|
Pang, Jiahui
|
|
|
|
1 |
p. 82-89
|
artikel
|
| 7 |
B cell dysfunction in chronic hepatitis B virus infection
|
Ma, Lijie
|
|
|
|
1 |
p. 11-15
|
artikel
|
| 8 |
Bile acid metabolism and signaling in liver disease and therapy
|
Chiang, John Y.L.
|
|
2017
|
|
1 |
p. 3-9
7 p.
|
artikel
|
| 9 |
Bile acid metabolism and signaling in liver diseases: Emerging trends of liver research and therapy
|
Chiang, John Y.L.
|
|
2017
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 10 |
Bile acid receptors and gastrointestinal functions
|
Ticho, Alexander L.
|
|
2019
|
|
1 |
p. 31-39
|
artikel
|
| 11 |
Bile acid receptors link nutrient sensing to metabolic regulation
|
Li, Jibiao
|
|
2017
|
|
1 |
p. 17-25
9 p.
|
artikel
|
| 12 |
Bile acids as global regulators of hepatic nutrient metabolism
|
Hylemon, Phillip B.
|
|
2017
|
|
1 |
p. 10-16
7 p.
|
artikel
|
| 13 |
Cellular crosstalk during cholestatic liver injury
|
Thomson, Joanne
|
|
2017
|
|
1 |
p. 26-33
8 p.
|
artikel
|
| 14 |
Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation
|
Li, Yuan
|
|
2019
|
|
1 |
p. 65-74
|
artikel
|
| 15 |
Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center
|
Chaikajornwat, Jukkaphop
|
|
|
|
1 |
p. 30-38
|
artikel
|
| 16 |
Corrigendum to “Long non-coding RNA in liver metabolism and disease: Current status” [Liver Res. 1 (2017) 163–167]
|
Zhao, Yulan
|
|
|
|
1 |
p. 99
|
artikel
|
| 17 |
Current and emerging therapies for alcohol-associated hepatitis
|
Idalsoaga, Francisco
|
|
|
|
1 |
p. 35-46
|
artikel
|
| 18 |
Cytokines and fatty liver diseases
|
Niederreiter, Lukas
|
|
|
|
1 |
p. 14-20
|
artikel
|
| 19 |
Diagnostic and therapeutic potentials of microRNAs in cholangiopathies
|
Kennedy, Lindsey
|
|
2017
|
|
1 |
p. 34-41
8 p.
|
artikel
|
| 20 |
Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice
|
Abdelsalam, Mayadah M.
|
|
|
|
1 |
p. 71-81
|
artikel
|
| 21 |
Editorial Board
|
|
|
2019
|
|
1 |
p. ii
|
artikel
|
| 22 |
Editorial Board
|
|
|
|
|
1 |
p. ii
|
artikel
|
| 23 |
Editorial Board
|
|
|
|
|
1 |
p. ii
|
artikel
|
| 24 |
Editorial Board
|
|
|
|
|
1 |
p. ii
|
artikel
|
| 25 |
Editorial Board
|
|
|
|
|
1 |
p. ii
|
artikel
|
| 26 |
Editorial Board
|
|
|
|
|
1 |
p. ii
|
artikel
|
| 27 |
Endoplasmic reticulum stress and liver diseases
|
Liu, Xiaoying
|
|
2019
|
|
1 |
p. 55-64
|
artikel
|
| 28 |
Endoscopic sequential therapy for portal hypertension: Concept and clinical efficacy
|
Wang, Xing
|
|
|
|
1 |
p. 7-10
|
artikel
|
| 29 |
Expert consensus on split-liver transplantation
|
|
|
|
|
1 |
p. 1-6
|
artikel
|
| 30 |
Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases
|
Eguchi, Akiko
|
|
|
|
1 |
p. 30-34
|
artikel
|
| 31 |
Fatty liver diseases: Recent advances and challenges
|
Wang, Hua
|
|
|
|
1 |
p. 1-2
|
artikel
|
| 32 |
Functional cure of chronic hepatitis B: Efforts and prospects
|
Mo, Zhishuo
|
|
|
|
1 |
p. 1-4
|
artikel
|
| 33 |
Functional roles of CCL5/RANTES in liver disease
|
Chen, Lili
|
|
|
|
1 |
p. 28-34
|
artikel
|
| 34 |
Functional roles of gut bacteria imbalance in cholangiopathies
|
Sato, Keisaku
|
|
2019
|
|
1 |
p. 40-45
|
artikel
|
| 35 |
Genetic variants in the 6p21.3 region influence hepatitis B virus clearance and chronic hepatitis B risk in the Han Chinese population
|
Huang, Jiancheng
|
|
|
|
1 |
p. 54-60
|
artikel
|
| 36 |
Granulocyte colony-stimulating factor reduces biliary fibrosis and ductular reaction in a mouse model of chronic cholestasis
|
Le, Trinh Van
|
|
|
|
1 |
p. 90-98
|
artikel
|
| 37 |
Gut microbiota, fatty liver disease, and hepatocellular carcinoma
|
Chu, Huikuan
|
|
|
|
1 |
p. 43-51
|
artikel
|
| 38 |
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
|
Cho, Ye Eun
|
|
|
|
1 |
p. 16-25
|
artikel
|
| 39 |
Immune cells in alcohol-related liver disease
|
Xu, Honghai
|
|
|
|
1 |
p. 1-9
|
artikel
|
| 40 |
Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19
|
Higuera-de la Tijera, Fátima
|
|
|
|
1 |
p. 21-27
|
artikel
|
| 41 |
Incidence, mortality, and risk factors of immunotherapy-associated hepatotoxicity: A nationwide hospitalization analysis
|
Weissman, Simcha
|
|
|
|
1 |
p. 28-32
|
artikel
|
| 42 |
Levels of circulating follicular helper T cells, T helper 1 cells, and the prognostic significance of soluble form of CD40 ligand on survival in patients with alcoholic cirrhosis
|
Hollister, Kristin
|
|
|
|
1 |
p. 52-59
|
artikel
|
| 43 |
Lipid and energy metabolism in Wilson disease
|
Mazi, Tagreed A.
|
|
|
|
1 |
p. 5-14
|
artikel
|
| 44 |
Marked elevation of serum alpha-fetoprotein following Clonorchis sinensis infection: A rare case report
|
Lin, Ying
|
|
|
|
1 |
p. 45-49
|
artikel
|
| 45 |
Molecular mechanisms of autophagy and implications in liver diseases
|
Wu, Yuankai
|
|
|
|
1 |
p. 56-70
|
artikel
|
| 46 |
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways☆
|
Ryu, Tom
|
|
|
|
1 |
p. 1-8
|
artikel
|
| 47 |
New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile
|
Wang, Helen H.
|
|
2017
|
|
1 |
p. 42-53
12 p.
|
artikel
|
| 48 |
Novel insights into the impact of liver inflammatory responses on primary liver cancer development
|
Ait-Ahmed, Yeni
|
|
|
|
1 |
p. 26-34
|
artikel
|
| 49 |
Nutrient mTORC1 signaling contributes to hepatic lipid metabolism in the pathogenesis of non-alcoholic fatty liver disease
|
Chen, Hanqing
|
|
|
|
1 |
p. 15-22
|
artikel
|
| 50 |
Physical activity and exercise in liver cancer
|
Chen, Haiyan
|
|
|
|
1 |
p. 22-33
|
artikel
|
| 51 |
Plasma angiopoietin 2 as a novel prognostic biomarker in alcohol-related cirrhosis and hepatitis
|
Kronsten, Victoria Tatiana
|
|
|
|
1 |
p. 21-29
|
artikel
|
| 52 |
Portopulmonary hypertension: Current developments and future perspectives
|
Xu, Huawei
|
|
|
|
1 |
p. 10-20
|
artikel
|
| 53 |
Protective effects of cyclosporine and its analog NIM-811 in a murine model of hepatic ischemia-reperfusion injury
|
Hefler, Joshua
|
|
|
|
1 |
p. 46-53
|
artikel
|
| 54 |
Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021
|
Ding, Wen-Xing
|
|
|
|
1 |
p. 50-57
|
artikel
|
| 55 |
Risk factors for very low-level viremia in patients with chronic hepatitis B virus infection: A single-center retrospective study
|
Lu, Jiahui
|
|
|
|
1 |
p. 39-44
|
artikel
|
| 56 |
Rodent models of fatty liver diseases
|
Bertola, Adeline
|
|
|
|
1 |
p. 3-13
|
artikel
|
| 57 |
Role of gut microbiota in the development of non-alcoholic fatty liver disease
|
Wang, Xuemei
|
|
2019
|
|
1 |
p. 25-30
|
artikel
|
| 58 |
Role of sterile inflammation in fatty liver diseases
|
Chen, Yonglin
|
|
|
|
1 |
p. 21-29
|
artikel
|
| 59 |
Role of the portal system in liver regeneration: From molecular mechanisms to clinical management
|
Xu, Hanzhi
|
|
|
|
1 |
p. 1-10
|
artikel
|
| 60 |
Severe bile duct complication after yttrium-90 radioembolization therapy in a patient with recurrent hepatocellular carcinoma after liver transplantation: A case report
|
Zhang, Jian-Wen
|
|
|
|
1 |
p. 33-35
|
artikel
|
| 61 |
Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells
|
Liu, Hao
|
|
2017
|
|
1 |
p. 70-79
10 p.
|
artikel
|
| 62 |
Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases
|
Kwong, Eric K.
|
|
2019
|
|
1 |
p. 19-24
|
artikel
|
| 63 |
Targeting nuclear receptors for NASH/MASH: From bench to bedside
|
Sinha, Rohit A.
|
|
|
|
1 |
p. 34-45
|
artikel
|
| 64 |
The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
|
Feng, Dechun
|
|
|
|
1 |
p. 23-27
|
artikel
|
| 65 |
The expression status of ZIC2 is an independent prognostic marker of hepatocellular carcinoma
|
Kong, Qinglei
|
|
|
|
1 |
p. 40-46
|
artikel
|
| 66 |
The role of adipose tissue in fatty liver diseases
|
Parker, Richard
|
|
|
|
1 |
p. 35-42
|
artikel
|
| 67 |
The role of gut microbiota in liver disease development and treatment
|
Wang, Lijun
|
|
2019
|
|
1 |
p. 3-18
|
artikel
|
| 68 |
The roles of zinc finger proteins in non-alcoholic fatty liver disease
|
Li, Guoqiang
|
|
|
|
1 |
p. 35-39
|
artikel
|
| 69 |
Transcription networks in liver development and acute liver failure
|
Feng, Rilu
|
|
|
|
1 |
p. 47-55
|
artikel
|
| 70 |
Transgenic overexpression of steroid sulfatase alleviates cholestasis
|
Jiang, Mengxi
|
|
2017
|
|
1 |
p. 63-69
7 p.
|
artikel
|
| 71 |
Viral hepatitis E: Clinical manifestations, treatment, and prevention
|
Luo, Qiumin
|
|
|
|
1 |
p. 11-21
|
artikel
|
Tijdschrift beschrijving